Hochman Cole Investment Advisors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,936
Closed -$381K 125
2020
Q3
$381K Buy
10,936
+417
+4% +$14.6K 0.19% 77
2020
Q2
$326K Hold
10,519
0.18% 85
2020
Q1
$326K Sell
10,519
-195
-2% -$6.64K 0.22% 74
2019
Q4
$398K Hold
10,714
0.22% 75
2019
Q3
$365K Hold
10,714
0.23% 75
2019
Q2
$440K Sell
10,714
-3,433
-24% -$136K 0.26% 74
2019
Q1
$570K Buy
14,147
+378
+3% +$15.1K 0.34% 59
2018
Q4
$570K Hold
13,769
0.39% 55
2018
Q3
$576K Hold
13,769
0.36% 53
2018
Q2
$474K Buy
13,769
+3,250
+31% +$111K 0.31% 60
2018
Q1
$354K Sell
10,519
-72
-0.7% -$2.48K 0.25% 66
2017
Q4
$364K Buy
10,591
+72
+0.7% +$2.46K 0.23% 65
2017
Q3
$356K Sell
10,519
-112
-1% -$3.6K 0.23% 64
2017
Q2
$339K Hold
10,631
0.23% 66
2017
Q1
$345K Buy
10,631
+112
+1% +$3.53K 0.25% 62
2016
Q4
$324K Hold
10,519
0.23% 64
2016
Q3
$338K Hold
10,519
0.25% 61
2016
Q2
$351K Hold
10,519
0.29% 55
2016
Q1
$296K Hold
10,519
0.25% 60
2015
Q4
$322K Buy
+10,519
New +$331K 0.27% 58

Other funds holding PFE

Hochman Cole Investment Advisors's PFE Position: Q4 2020 in Review

Hochman Cole Investment Advisors sold out of Pfizer (PFE) in Q4 2020, closing a stake of 10,936 shares — an estimated $381K sold.

Hochman Cole Investment Advisors first reported a position in PFE in Q4 2015 and held it in 20 quarters. The position peaked at $576K in Q3 2018. 2,674 funds tracked by Wall St. Rank hold PFE as of Q4 2020.

  • Hochman Cole Investment Advisors reported no remaining Pfizer position as of Q4 2020 after selling out during the quarter.
  • Hochman Cole Investment Advisors sold 10,936 Pfizer shares in Q4 2020, an estimated $381K.
  • Hochman Cole Investment Advisors first reported a position in Pfizer in Q4 2015 and held it in 20 quarters.
  • Hochman Cole Investment Advisors's Pfizer position peaked at $576K in Q3 2018.
  • 2,674 funds tracked by Wall St. Rank held Pfizer as of Q4 2020.

Based on Hochman Cole Investment Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.